Exhibit 99.2
XPERI INC.
GAAP TO NON-GAAP RECONCILIATIONS
(in thousands)
(unaudited)
Twelve Months Ended | Six Months Ended | |||||||
December 31, 2021 | June 30, 2022 | |||||||
GAAP Loss before taxes | $ | (160,238 | ) | $ | (50,993 | ) | ||
Pro forma adjustments for transaction accounting | (1,675 | ) | (837 | ) | ||||
Pro forma adjustments for autonomous entity | 1,020 | 510 | ||||||
Pro forma other adjustments | (3,000 | ) | (1,500 | ) | ||||
Interest expense | 3,000 | 1,500 | ||||||
Other income | (1,590 | ) | (226 | ) | ||||
Depreciation expense | 22,584 | 10,707 | ||||||
Amortization expense | 105,311 | 29,553 | ||||||
Merger and integration-related costs: | ||||||||
Transaction and other related costs recorded in selling, general and administrative | — | 2,058 | ||||||
Restructuring and asset impairment costs recorded in selling, general and administrative | (818 | ) | — | |||||
Severance and retention recorded in cost of revenue, excluding depreciation and amortization of intangible assets | 849 | 106 | ||||||
Severance and retention recorded in research, development and other | 2,681 | 97 | ||||||
Severance and retention recorded in selling, general and administrative | 2,890 | (35 | ) | |||||
Stock-based compensation expense: | ||||||||
Cost of revenue | 1,999 | 1,398 | ||||||
Research, development and other | 17,914 | 10,780 | ||||||
Selling, general and administrative | 22,873 | 11,501 | ||||||
|
|
|
| |||||
Non-GAAP Adjusted EBITDA | $ | 13,801 | $ | 14,619 | ||||
|
|
|
|